The growth rate of science and engineering (S&E) research space at US biomedical institutions declined 2.2% from fiscal year (FY) 2007 to FY 2009 to comprise 21.8 million net assignable square feet (NASF), according to the NSF’s latest “Science and Engineering Research Facilities” report. The report reflects the latest in a series of surveys that […]
With improving economic data and a potential resolution to the European debt crisis, the Dow Jones Industrial Average, S&P 500 and NASDAQ jumped 9.5%, 10.8% and 11.1% in October, respectively. Economic indicators showed expanding US durable goods orders, outside of transportation, and a slightly improved housing sector. Quarterly earnings were mostly positive, and GDP growth […]
Company Announcements For the fiscal year ending March 31, sales for Takara Bio’s Genetic Engineering Research unit fell 4.8% to ¥15,882 million ($185 million) (see IBO 9/30/11). Sales of research reagents and contract research services were each unchanged. Scientific instrument sales declined significantly due to last year’s demand from public agencies. The unit aims for […]
Second-quarter revenues for the IBO Lab Equipment/Consumables Sales Index expanded 7.5%, 4.5% excluding currency, to $4,056.00 million. Operating profits for the Index climbed 6.3% to $721.23 million, but adjusted operating margin declined 80 basis points to 17.1% of sales. Biohit’s second-quarter sales grew 2.4% to €10.2 million ($14.8 million = €0.69 = $1) due to […]
San Diego, CA 10/6/11—Illumina has announced that it expects third-quarter revenues of $235 million. This figure would be a 1% decrease year over year and an 18% decline from the second quarter. The company attributed the forecast to: uncertainty about US and European research-funding levels that resulted in purchasing delays for both instruments and consumables; […]
Two recent announcements by Thermo Fisher Scientific illustrate the company’s commitment to its diagnostics business. Diagnostics is not a new market for the company but, as the news made clear, it is one in which the company has a solid position and one for which it is investing in research. Revenue for Thermo Fisher Scientific’s […]
Instrument and laboratory product company executives hold divergent opinions on the industry outlook for the next six months and related issues, according to the latest IBO Business Climate Survey. The survey is conducted twice yearly. This season’s survey of IBO subscribers was conducted anonymously via a webpage questionnaire during late September and early October. Twenty-five […]
Calendar-year third quarter ended with increased recessionary fears due to the lingering European sovereign debt crisis, a deteriorating US economic outlook by the US Federal Reserve and weak economic data from China. Investors’ anxieties were further heightened on September 20, when the International Monetary Fund lowered its growth forecasts for both the US and Europe. […]
Recovery for material characterization solutions for the metals and mining industry, along with sustained growth for products used by the electronics industry and strong demand from emerging territories, boosted sales for British companies Oxford Instruments and Spectris. For the fiscal year 2011 ending March 31, Oxford Instruments’ sales climbed 24.0% to £262.3 million ($409.8 million […]
Company Announcements Shimadzu announced in June a collaborative research agreement with Japan’s National Cancer Center in the areas of early cancer diagnosis, pharmacokinetic analysis and medical treatments. In June, JEOL opened a company based in New Delhi, India, dedicated to analytical instruments. Blue Star remains the company’s Indian distributor but will concentrate on Electron Optics […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
